| Tag | Content |
|---|
EnhancerAtlas ID | HS093-16507 |
Organism | Homo sapiens |
Tissue/cell | HL-60 |
Coordinate | chr2:28939960-28940810 |
SNPs | | Number: 1 | ID | Chromosome | Position | Genome Version |
|
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| NFAT5 | MA0606.1 | chr2:28940106-28940116 | ATTTTCCATT | + | 6.02 | | NFATC1 | MA0624.1 | chr2:28940106-28940116 | ATTTTCCATT | + | 6.02 | | NFATC3 | MA0625.1 | chr2:28940106-28940116 | ATTTTCCATT | + | 6.02 |
|
| | Number of super-enhancer constituents: 2 | ID | Coordinate | Tissue/cell |
| SE_02169 | chr2:28939958-28940678 | Aorta | | SE_41111 | chr2:28938705-28940799 | Left_Ventricle |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH02I028713 | chr2 | 28936139 | 28941575 |
|
Enhancer Sequence | TCTAACCAAT TTTTATTTTG TTGATGAAAA CTGAAAGCGG AAGCTAGAAG AATGGGGGGA 60
TTGTCCTCTT TTCTATATAT TTTTTTCTTT TTGATGTCCT TTACTTCAAG TTAAGCCTGG 120
TGTTTGCTTT AATCACAGCA GAAAGCATTT TCCATTTCAG GGAAAGGAGA GAACAGGCCA 180
TAAACCCTGT CCCCTGTTTG TTCTCCAACT ACCCATTTTT GTCCTTTGCC CTGCCATGTC 240
TTTTCCCCCT CGTTTGCTTC TCCTTTCTTT GTTGATTTCT CAGTTCTTTT CTGGCCTCAC 300
TCAAAATGGC AGAAATTACG CAACCTAGTA CTTTTTTACA CAAGCTCCTT TAGTGTCAAG 360
GATTCATCAA GTGCCTGCCA TGTGCCGGAA CTGTTCTAGA TGCCGAGAAT ACTACCATGA 420
ATGAAATAGA CAGAAATCCC GGCTGTCATT GGGCTTTGTC TGAGGGCCAT TGGGGAAGGC 480
CTCTCAAAGG AAGTGATAGC TGAGCTGGGA TCTGAGTCAT GAAGAGGAGT GAGCCCAGGG 540
GACAACAGCT GCAAGAGTGT GCCAATGGGA GAGACCAGCC CAGCAAAAAG GAGAAGCATA 600
AGTCTGGTGC ATTCCAGGGA CAGGAAGGAA TGGGGCAGGG TGCCTTTAAG AGAAAAGCAT 660
CAGTTTGGAT GAGGAGGGAT GTAGGGTCGG GAATACAAAA TAAGAGTAAT TATGGCTGGG 720
CACAATAGCT CACACCTGTA ATCCCAGGAC TTTGGGAGGC CAAGGTGGGC GGATCACTTG 780
AGGTCGGGAG TTAGAGACCA GCCTGGCCAA CATGGCGAAA CCCTGTCTCT ACCAAAAATA 840
CAAAAATTAG 850
|
